Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bhalla, US
Gaurav Bhalla, Hercules, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090247434 | PREPARATION OF A MOLYBDENUM AMIDE ADDITIVE COMPOSITION AND THE LUBRICATING OIL COMPOSITIONS CONTAINING SAME - The invention is directed to oil soluble additive compositions, lubricating oil compositions, and additive concentrates comprising the salt of (1) a molybdenum oxide, sulfide, or oxysulfide and (2) an amide reaction product of a carboxylic acid component and a polyamine component wherein the charge mole ratio (CMR) of the carboxylic acid component to the polyamine component is about 2:1 to 1:1. | 10-01-2009 |
| 20100152079 | LUBRICATING OIL COMPOSITIONS CONTAINING A TETRAALKYL-NAPTHALENE-1,8 DIAMINE ANTIOXIDANT - Disclosed is a lubricating oil composition containing an oil of lubricating viscosity and a N,N,N′,N′-tetraalkyl-naphthalene-1,8-diamine and at least one additive selected from antioxidants, dispersants, and detergents which together provide superior oxidation inhibition and are suitable lubricants for automotive and truck crankcase lubricants; as well as transmission lubricants, gear lubricants, hydraulic fluids, compressor oils, diesel and marine lubricants. | 06-17-2010 |
| 20110077180 | PREPARATION OF A SULFURIZED MOLYBDENUM AMIDE COMPLEX AND ADDITIVE COMPOSITIONS HAVING LOW RESIDUAL ACTIVE SULFUR - The invention is directed to oil soluble additive compositions, lubricating oil compositions derived from a process for preparing a sulfurized oil soluble molybdenum complex having reduced active sulfur comprising: reacting an acidic molybdenum compound with an amide derived from a carboxylic acid component an polyamine component in a ratio from 2:1 to 1:1; there after sulfurizing to provide a sulfurized oil soluble molybdenum which is subsequently treated with at least one compound capable of reacting with the active sulfur of step b). | 03-31-2011 |
| 20110143979 | Lubricating oil compositions - A lubricating oil composition is disclosed which comprises (a) a major amount of an oil of lubricating viscosity; (b) one or more non-halogen-containing oil-soluble titanium complexes comprising at least one ligand comprising an anion of a carboxylic acid; (c) one or more dispersants; and (d) one or more detergents, wherein the lubricating oil composition is free of any zinc dialkyldithiophosphate. | 06-16-2011 |
| 20110143980 | Lubricating oil compositions containing titanium complexes - A lubricating oil composition is disclosed which comprises (a) a major amount of an oil of lubricating viscosity; and (b) one or more non-halogen-containing oil-soluble titanium complexes comprising at least one ligand selected from the group consisting of (i) an anion of an α-, β- or γ-hydroxycarbonyl compound; (ii) an anion of an α-, β- or γ-hydroxycarboxylic acid, amide or ester; (iii) an anion of an α-, β- or γ-aminocarboxylic acid; and (iv) an anion of an α-, β- or γ-keto acid. | 06-16-2011 |
Jagmohan Bhalla, Washington, DC US
| Patent application number | Description | Published |
|---|---|---|
| 20090307825 | STERILE GLOVE WITH TOUCHLESS DONNING - A sterile glove includes a cuff that has an inside surface and an outside surface. The cuff is folded over at a fold when the glove is packaged and when it is initially removed from the package. The glove further includes a hand and finger portion. The glove further includes a detachable tab that is coupled to the cuff and includes a free end. The detachable tab is adapted to facilitate a donning of the glove before being detached. | 12-17-2009 |
| 20100037365 | STERILE GLOVE WITH TOUCHLESS DONNING - A sterile glove includes a cuff that has an inside surface and an outside surface. The cuff is folded over at a fold when the glove is packaged and when it is initially removed from the package. The glove further includes a hand and finger portion. The glove further includes a detachable tab that is coupled to the cuff and includes a free end. The detachable tab is adapted to facilitate a donning of the glove before being detached. | 02-18-2010 |
| 20110138518 | STERILE GLOVE WITH TOUCHLESS DONNING - A sterile glove includes a hand and finger portion and a cuff having an inside surface and an outside surface. The cuff is adapted to be folded over at a fold when the glove is packaged in a sterile package and the fold forms an opening for inserting a hand into the glove. A stretching mechanism is coupled substantially near or on the fold and is adapted to increase a size of the opening while donning the glove. At least a portion of the stretching mechanism is detachable. The stretching mechanism has an unstretched state and a stretched state, and the stretching mechanism is in the unstretched state when the glove is packaged. | 06-16-2011 |
Kapil Bhalla, Martinez, GA US
| Patent application number | Description | Published |
|---|---|---|
| 20100111943 | COMPOSITIONS AND METHODS FOR INHIBITING CANCER METASTASIS - It has been discovered that antagonists of acetylated heat shock proteins can inhibit or reduce tumor cell invasion or metastasis. Compositions and methods for inhibiting tumor cell invasion or metastasis are provided. One embodiment provides a pharmaceutical composition including a heat shock protein antagonist in an amount effective to inhibit or reduce tumor cell invasion or metastasis. Another embodiment provides a pharmaceutical composition including a heat shock protein deacetylase in an amount effective to inhibit or reduce secretion of heat shock proteins. Representative target heat shock proteins include, but are not limited to hsp90α and hsp70. Methods of treating cancer or inhibiting tumor cell invasion and metastasis are also provided. | 05-06-2010 |
Kapil N. Bhalla, Martinez, GA US
| Patent application number | Description | Published |
|---|---|---|
| 20100069458 | COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER - The invention relates to a combination comprising the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination. | 03-18-2010 |
Kapil N. Bhalla, Tampa, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20080200488 | Combinations Comprising a Protein Kinase Inhibitor Being a Pyrimidylaminobenzamide Compound and a Hsp90 Inhibitor Such as 17-Aag - The invention provides a pharmaceutical combination comprising: | 08-21-2008 |
| 20080200489 | Combination of Organic Compounds - The invention provides a pharmaceutical combination comprising: | 08-21-2008 |
| 20090215792 | METHOD OF TREATING CHRONIC MYELOGENOUS LEUKEMIA CELLS - Here, the inventors disclose the treatment of imatinib mesylate resistant chronic myelogenous leukemia cells with a cotreatment of vorinostat (SAHA, suberoylanilide hydroxamic acid) and dasatinib, a dual Abl/Src kinase (TK) inhibitor. Combined treatment of cultured human CML and BaF3 cells with vorinostat and dasatinib induced more apoptosis than either agent alone, as well as synergistically induced loss of clonogenic survival, which was associated with greater depletion of Bcr-Abl, p-CrkL and p-STAT5 levels. Co-treatment with dasatinib and vorinostat also attenuated the levels of Bcr-AblE255K and Bcr-AblT315I and induced apoptosis of BaF3 cells with ectopic expression of the mutant forms of Bcr-Abl. Finally, co-treatment of the primary CML cells with vorinostat and dasatinib induced more loss of cell viability and depleted Bcr-Abl or Bcr-AblT315I, p-STAT5 and p-CrkL levels than either agent alone. | 08-27-2009 |
| 20100227849 | LEUKEMIA TREATMENT METHOD AND COMPOSITION - A method of inducing high anti-leukemia activity responsive to the combination of hydroxamic acid analogue histone deacetylase inhibitors and PKC412 against human acute leukemia characterized as expressing phosphorylated (p)FLT3 kinase by a novel flow cytometry-based assay. | 09-09-2010 |
Kapll N. Bhalla, Tampa, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20110281902 | COMBINATIONS COMPRISING A PROTEIN KINASE INHIBITOR BEING A PYRIMIDYLAMINOBENZAMIDE COMPOUND AND A HSP90 INHIBITOR SUCH AS 17-AAG - The invention provides a pharmaceutical combination comprising: | 11-17-2011 |
Pooja Bhalla, Hercules, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080305401 | Lithium-ion electrolytes with fluoroester co-solvents - An embodiment lithium-ion battery comprising a lithium-ion electrolyte of ethylene carbonate; ethyl methyl carbonate; and at least one solvent selected from the group consisting of trifluoroethyl butyrate, ethyl trifluoroacetate, trifluoroethyl acetate, methyl pentafluoropropionate, and 2,2,2-trifluoroethyl propionate. Other embodiments are described and claimed. | 12-11-2008 |
Sandeep Bhalla, San Jose, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100121649 | METHODS AND SYSTEMS FOR USER REGISTRATION - A method and a system to register a user include using some user information stored and provided by a third party system. For example, the user may provide an identifier associated with the third party system. The identifier may be used to retrieve the user information. The user information may be used to at least partially complete the user registration. | 05-13-2010 |
Sanjeev Bhalla, Sunnyvale, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090112708 | Mobile Content Placement Reward System - The present invention is generally directed toward a system and methods of placing content, including advertising, content on a mobile device in response to an event in the operational lifecycle of the device. The event defines an opportunity between power-up and power-off when the user's attention is likely drawn to the device. The inserted content can be any media form including graphic, image, video, animation, audio or textual and can be fully interactive. The content is inserted before, during, or after an event in a minimally intrusive manner so as not to interfere with the communications features of the device. The system and method reward the user for each display of content. | 04-30-2009 |
| 20090112709 | Mobile Value Transfer System - The present invention provides for a financial value transfer system wherein financial value can be transferred between an account associated with a mobile telephone user and a stored value card. The transfer is facilitated using an interface on a mobile telecommunications device, thereby providing greater flexibility with the use of stored value cards | 04-30-2009 |
Shaifali Bhalla, Oak Park, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090221490 | Endothelin Receptors In Morphine Withdrawal - The present invention relates to compositions and methods for managing opioid tolerance and reducing opioid withdrawal. More specifically, the present invention provides for endothelin, endothelin receptors, and endothelin receptor antagonists and agonists as a means for managing G-protein activity in the context of opioid tolerance and withdrawal. | 09-03-2009 |
Shaifali Bhalla, Naperville, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100323456 | Endothelin Receptors in Morphine Withdrawal - The present invention relates to compositions and methods for managing opioid tolerance and reducing opioid withdrawal. More specifically, the present invention provides for endothelin, endothelin receptors, and endothelin receptor antagonists and agonists as a means for managing G-protein activity in the context of opioid tolerance and withdrawal. | 12-23-2010 |
Vijay Bhalla, Allen, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100215179 | Security Key Method In Semiconductor Manufacturing - The management of customer security keys by an integrated circuit manufacturer with automated material tracking among multiple circuit testers at multiple sites for programming keys into circuits. Limited key change methods plus sufficient key statuses provides processes for key handling. | 08-26-2010 |